Cirrhosis and hernia repair in a cohort of 6352 patients in a tertiary hospital Risk assessment and survival analysis

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
MEDICINE, v.101, n.45, article ID e31506, 9p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The prevalence of hernias in patient with cirrhosis can reach up to 40%. The pathophysiology of cirrhosis is closely linked to that of the umbilical hernia, but other types are also common in this population. The aim of this study is to evaluate factors that influence in the prognosis after hernia repair in patients with cirrhosis. A historical cohort of 6419 patients submitted to hernia repair was gathered. Clinical, epidemiological data and hernia characteristics were obtained. For patient with cirrhosis, data from exams, surgery and follow-up outcomes were also analyzed. Survival curves were constructed to assess the impact of clinical and surgical variables on survival. 342 of the 6352 herniated patients were cirrhotic. Patient with cirrhosis had a higher prevalence of umbilical hernia (67.5% x 24.2%, P<.001) and a lower prevalence of epigastric (1.8% x 9.0%, P<.001) and lumbar (0% x 0.18%, P=.022). There were no significant differences in relation to inguinal hernia (P=.609). Ascites was present in 70.1% of patient with cirrhosis and its prevalence was different in relation to the type of hernia (P<.001). The survival curve showed higher mortality for emergency surgery, MELD>14 and ascites (HR 12.6 [3.79-41.65], 4.5 [2.00-10.34], and 6.1 [1.15-20.70], respectively, P<.05). Hernia correction surgery in patient with cirrhosis has a high mortality, especially when performed under urgent conditions associated with more severe clinical conditions of patients, such as the presence of ascites and elevated MELD.
Palavras-chave
ascites, cirrhosis, complications, hernia, inguinal hernia, outcomes, surgery, survival, umbilical hernia
Referências
  1. AhmedAlenazi Abdulmajeed, 2017, Electron Physician, V9, P4806, DOI 10.19082/4806
  2. Andraus W, 2009, ABCD-ARQ BRAS CIR DI, V22, P222, DOI 10.1590/S0102-67202009000400008
  3. Asrani SK, 2021, HEPATOLOGY, V73, P2039, DOI 10.1002/hep.31583
  4. Belghiti J, 1997, SEMIN LIVER DIS, V17, P219, DOI 10.1055/s-2007-1007199
  5. Carbonell Alfredo M, 2005, Hernia, V9, P353, DOI 10.1007/s10029-005-0022-x
  6. Cho SW, 2012, ARCH SURG-CHICAGO, V147, P864, DOI 10.1001/archsurg.2012.1663
  7. Medeiros KAD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77925-y
  8. de Goede B, 2012, BEST PRACT RES CL GA, V26, P47, DOI 10.1016/j.bpg.2012.01.010
  9. del Olmo JA, 2003, WORLD J SURG, V27, P647, DOI 10.1007/s00268-003-6794-1
  10. Dokmak S, 2012, J VISC SURG, V149, pE32, DOI 10.1016/j.jviscsurg.2012.04.002
  11. Ducatti L, 2021, ABCD-ARQ BRAS CIR DI, V34, DOI 10.1590/0102-672020210002e1622
  12. Eker HH, 2011, SURGERY, V150, P542, DOI 10.1016/j.surg.2011.02.026
  13. Kavic Michael S, 2005, JSLS, V9, P249
  14. Kim SW, 2020, HERNIA, V24, P481, DOI 10.1007/s10029-019-02043-2
  15. Li X, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5308308
  16. Marsman HA, 2007, SURGERY, V142, P372, DOI 10.1016/j.surg.2007.05.006
  17. Martines DR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72647-7
  18. Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y
  19. Oh HK, 2011, WORLD J SURG, V35, P1229, DOI 10.1007/s00268-011-1007-9
  20. Pinheiro RS, 2020, ANN MED SURG, V49, P9, DOI 10.1016/j.amsu.2019.11.009
  21. Primatesta P, 1996, INT J EPIDEMIOL, V25, P835, DOI 10.1093/ije/25.4.835
  22. Simegn AE, 2022, ANN MED SURG, V75, DOI 10.1016/j.amsu.2022.103397
  23. Suguita FY, 2017, SURG ENDOSC, V31, P3939, DOI 10.1007/s00464-017-5426-z
  24. Ziser A, 2001, Curr Opin Anaesthesiol, V14, P707, DOI 10.1097/00001503-200112000-00018